This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hunter Wise Securities Assists In Major Acquisition By NASDAQ Company

IRVINE, Calif., June 8, 2011 /PRNewswire/ -- Hunter Wise Securities, LLC, ( www.hunterwise.com), announced today that its client, leading privately-held spinal implant device maker SeaSpine, Inc., has been acquired by Integra LifeSciences Holdings Corporation (NASDAQ: IART) for $89 million in cash, subject to certain post-closing adjustments.  After the combination, the spine and orthobiologics portfolio is now the largest component of Integra's orthopedics revenue category.

"SeaSpine is an ideal strategic fit for Integra, as the combination brings together two well-respected innovators in the spinal fusion market," said Stuart Essig, Integra's Chief Executive Officer. "Integra has a track record of successfully executing on and integrating strategic transactions, and we expect to realize the benefits of this combination in both our top line growth and earnings per share over the long-term."

SeaSpine generated approximately $50 million in revenue in 2010 and has grown profitably each year since its inception in 2002.  Hunter Wise Managing Director Paul Fejtek based in Irvine, CA served as advisor to SeaSpine.  "The entire management team at SeaSpine has been a pleasure to work with and they are dedicated, energetic, and passionate about their business and pioneering new solutions for the spinal implant market," said Mr. Fejtek.  

"Completing the transaction was an exercise of endurance and overcoming obstacles, much like climbing a mountain," he said.  While working on the deal last year Mr. Fejtek actually spent time in Nepal climbing Mt. Everest, and checked in with his client periodically by satellite phone.  Ironically the closing date of the acquisition, May 23, 2011, was exactly one year to the day that Paul and his wife Denise stood on the summit of Mt. Everest, Earth's highest peak at 29,029 feet.  

What's next after those milestones? "I certainly wish continued success to SeaSpine as the newest member of the Integra organization, and I'm looking forward to my next deal," Mr. Fejtek said.  "I also plan to finish writing my business book.  It's called 'Steps to the Summit', an adventure story combined with valuable life lessons learned while climbing the highest peaks on each of the world's seven continents." ( http://www.fejteksevensummits.blogspot.com/)

SeaSpine ( www.seaspine.com), Vista, CA, "The Next Wave in Spine Technology" develops and distributes a full range of spinal fixation products, including both hardware and biologics.  Products are offered to customers across the U.S. and in select markets in Europe.

Integra LifeSciences ( www.integralife.com), headquartered in Plainsboro, NJ, is a world leader in medical devices, dedicated to limiting uncertainty for surgeons so they can concentrate on providing the best patient care.  It offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery.

Hunter Wise ( www.hunterwise.com), Irvine, CA is a specialized investment bank providing the highest quality level of corporate financing, merger, acquisition, divestiture and advisory services. The Company's clients include middle market privately-held businesses as well as small to medium-sized public companies.  Hunter Wise has 15 offices in the U.S. as well as locations in Beijing and London.  

CONTACT: Paul Fejtek, Managing DirectorHunter Wise Financial Group, LLCHunter Wise Securities, LLC2361 Campus Dr., Suite 100 Irvine, CA 92612

(949) 732-4103 pfejtek@hunterwise.com

SOURCE Hunter Wise Securities, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,982.59 +22.02 0.13%
S&P 500 1,978.91 +0.57 0.03%
NASDAQ 4,444.9090 -4.6550 -0.10%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs